MX2014009899A - Antibioticos peptidicos lineales. - Google Patents
Antibioticos peptidicos lineales.Info
- Publication number
- MX2014009899A MX2014009899A MX2014009899A MX2014009899A MX2014009899A MX 2014009899 A MX2014009899 A MX 2014009899A MX 2014009899 A MX2014009899 A MX 2014009899A MX 2014009899 A MX2014009899 A MX 2014009899A MX 2014009899 A MX2014009899 A MX 2014009899A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- linear peptide
- peptide antibiotics
- broad spectrum
- bioactivity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
En el presente documento se proporcionan compuestos antibacterianos, en que los compuestos, en algunas realizaciones, tienen bioactividad de amplio espectro. Los compuestos que se proporcionan en el presente documento pueden superar, en otras realizaciones, la resistencia transmitida por mutaciones de un solo aminoácido en las posiciones definidas de Peptidasas de Señal bacterianas (SPasas) y, en otras realizaciones, pueden proporcionar un amplio espectro de bioactividad antibiótica. Además, se proporcionan composiciones farmacéuticas y métodos de tratamiento que usan los compuestos que se describen en el presente documento.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261599851P | 2012-02-16 | 2012-02-16 | |
US201261730928P | 2012-11-28 | 2012-11-28 | |
PCT/US2013/026520 WO2013123456A1 (en) | 2012-02-16 | 2013-02-15 | Linear peptide antibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014009899A true MX2014009899A (es) | 2015-03-09 |
MX357561B MX357561B (es) | 2018-07-13 |
Family
ID=48982724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014009899A MX357561B (es) | 2012-02-16 | 2013-02-15 | Antibióticos peptídicos lineales. |
Country Status (12)
Country | Link |
---|---|
US (3) | US8999922B2 (es) |
EP (1) | EP2814807A4 (es) |
JP (2) | JP2015509942A (es) |
KR (1) | KR20140132367A (es) |
CN (1) | CN104254518A (es) |
AR (1) | AR091310A1 (es) |
CA (1) | CA2864669A1 (es) |
EA (1) | EA201491511A1 (es) |
HK (1) | HK1205736A1 (es) |
MX (1) | MX357561B (es) |
TW (1) | TWI601746B (es) |
WO (1) | WO2013123456A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8999922B2 (en) | 2012-02-16 | 2015-04-07 | Rqx Pharmaceuticals, Inc. | Linear peptide antibiotics |
CA2905237A1 (en) * | 2013-03-15 | 2014-09-18 | Adaerata, Limited Partnership | Small molecule modulators of pcsk9 and methods of use thereof |
CA2921082A1 (en) * | 2013-08-14 | 2015-02-19 | Rqx Pharmaceuticals, Inc. | Linear peptide antibiotics |
CA3011410C (en) | 2015-04-14 | 2023-10-10 | B-Organic Films Corp. | Antiviral and antibacteria agents based on quaternary ammonium compound complexed with boric acid and its derivatives |
AU2017273857B2 (en) | 2016-06-01 | 2021-08-19 | Athira Pharma, Inc. | Compounds |
JP7164521B2 (ja) | 2016-06-21 | 2022-11-01 | オリオン・オフサルモロジー・エルエルシー | 炭素環式プロリンアミド誘導体 |
DK3472149T3 (da) | 2016-06-21 | 2023-11-27 | Orion Ophthalmology LLC | Heterocykliske prolinamidderivater |
KR102042600B1 (ko) * | 2018-02-13 | 2019-11-08 | 전북대학교산학협력단 | 항산화 및 항염증 활성을 갖는 홍갯지렁이 유래 신규 펩타이드 및 이의 이용 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499082A (en) * | 1983-12-05 | 1985-02-12 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid peptides |
SI0932617T1 (en) * | 1996-10-18 | 2002-06-30 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
IL129407A0 (en) * | 1996-10-18 | 2000-02-17 | Vertex Pharma | Inhibitors of serine proteases particularly hepatitis C virus NS3 protease pharmaceutical compositions containing the same and the use thereof |
GB9623908D0 (en) * | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
GB9902399D0 (en) | 1999-02-03 | 1999-03-24 | Smithkline Beecham Plc | Compounds |
JP2003522153A (ja) * | 2000-02-10 | 2003-07-22 | インターミューン インコーポレイテッド | ブドウ球菌属ビルレンスの新規アミノ酸インヒビターおよびペプチドインヒビター |
AR029851A1 (es) * | 2000-07-21 | 2003-07-16 | Dendreon Corp | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c |
SV2003000617A (es) * | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
US7244815B2 (en) * | 2001-05-23 | 2007-07-17 | The Curators Of The University Of Missouri | Attachment and elaboration strategies for inverse peptide synthesis |
WO2002095007A2 (en) * | 2001-05-23 | 2002-11-28 | Dendreon San Diego Llc | Conjugates activated by cell surface proteases and therapeutic uses thereof |
KR101145252B1 (ko) * | 2003-01-08 | 2012-05-24 | 유니버시티 오브 워싱톤 | 항균제 |
MY148123A (en) * | 2003-09-05 | 2013-02-28 | Vertex Pharma | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
KR20130028078A (ko) * | 2010-03-09 | 2013-03-18 | 머크 캐나다 인크. | 베타-락탐 항박테리아제의 활성을 강화시키는 가교된 리포글리코펩티드 |
US8999922B2 (en) | 2012-02-16 | 2015-04-07 | Rqx Pharmaceuticals, Inc. | Linear peptide antibiotics |
-
2013
- 2013-02-15 US US13/769,130 patent/US8999922B2/en not_active Expired - Fee Related
- 2013-02-15 KR KR1020147025651A patent/KR20140132367A/ko not_active Application Discontinuation
- 2013-02-15 CN CN201380020376.2A patent/CN104254518A/zh active Pending
- 2013-02-15 EA EA201491511A patent/EA201491511A1/ru unknown
- 2013-02-15 WO PCT/US2013/026520 patent/WO2013123456A1/en active Application Filing
- 2013-02-15 AR ARP130100482 patent/AR091310A1/es unknown
- 2013-02-15 JP JP2014557853A patent/JP2015509942A/ja active Pending
- 2013-02-15 EP EP13749947.1A patent/EP2814807A4/en not_active Withdrawn
- 2013-02-15 CA CA2864669A patent/CA2864669A1/en not_active Abandoned
- 2013-02-15 MX MX2014009899A patent/MX357561B/es active IP Right Grant
- 2013-02-18 TW TW102105674A patent/TWI601746B/zh not_active IP Right Cessation
-
2015
- 2015-02-25 US US14/631,762 patent/US9708368B2/en not_active Expired - Fee Related
- 2015-06-29 HK HK15106179.3A patent/HK1205736A1/xx unknown
-
2017
- 2017-06-09 US US15/618,337 patent/US20170275334A1/en not_active Abandoned
-
2018
- 2018-03-08 JP JP2018042357A patent/JP2018135334A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HK1205736A1 (en) | 2015-12-24 |
US20130217619A1 (en) | 2013-08-22 |
US8999922B2 (en) | 2015-04-07 |
TWI601746B (zh) | 2017-10-11 |
CA2864669A1 (en) | 2013-08-22 |
EA201491511A1 (ru) | 2014-12-30 |
US9708368B2 (en) | 2017-07-18 |
JP2018135334A (ja) | 2018-08-30 |
CN104254518A (zh) | 2014-12-31 |
WO2013123456A1 (en) | 2013-08-22 |
TW201341403A (zh) | 2013-10-16 |
EP2814807A1 (en) | 2014-12-24 |
EP2814807A4 (en) | 2015-10-07 |
US20170275334A1 (en) | 2017-09-28 |
US20150166605A1 (en) | 2015-06-18 |
KR20140132367A (ko) | 2014-11-17 |
JP2015509942A (ja) | 2015-04-02 |
MX357561B (es) | 2018-07-13 |
AR091310A1 (es) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX357561B (es) | Antibióticos peptídicos lineales. | |
WO2012166665A3 (en) | Broad spectrum antibiotics | |
MX2015006340A (es) | Antibioticos macrociclicos de amplio espectro. | |
MX2016001927A (es) | Antibióticos de péptidos lineales. | |
MX2013012542A (es) | Compuestos de amida y aplicacion farmaceutica para el mismo. | |
MX2014011067A (es) | Analogos de antibiótico de arilomicina de amplio espectro. | |
EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
NZ602544A (en) | Crystalline forms of a macrolide, and uses therefor | |
WO2011113606A8 (en) | Anti-infective compounds | |
GB201016733D0 (en) | Compounds and their use | |
MX2013003035A (es) | Analogos de arilomicina como antibióticos de amplio espectro. | |
MX2018006190A (es) | Antibioticos de amplio espectro macrociclico. | |
MX364942B (es) | Peptidos antimicrobianos. | |
MX2018006199A (es) | Antibioticos de amplio espectro macrociclico. | |
WO2014022382A3 (en) | Antibacterial protein kinase inhibitors | |
PH12019501904A1 (en) | Macrocyclic broad spectrum antibiotics | |
MX2016007626A (es) | Peptido antimicrobiano y usos del mismo. | |
PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
PH12015500518A1 (en) | Tricyclic tetrahydroquinoline antibacterial agents | |
MX2015015251A (es) | Derivados de la quinolona. | |
PH12015501428A1 (en) | Antibacterial compounds | |
UA94177C2 (en) | antimicrobial composition | |
WO2015063608A9 (en) | Use of peptides in antibiotic resistance | |
EP2772248A4 (en) | PHARMACEUTICAL COMPOSITION AND KIT FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
AU2011904604A0 (en) | Gram positive bacterial infections treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |